The FDA has granted clearance to the first AI-powered medical device to assist physicians in detecting all 3 common skin cancers. Providing a more accurate way of identifying skin cancer will ...

Handheld, AI-powered device is the first of its kind and could help doctors detect skin cancer earlier, according to its maker. Latest U.S.

NovaScan, after completing a round of financing, says it will develop a commercial version of its MarginScan product that aids in surgery to treat skin cancer. NovaScan's device is used in Mohs ...

DermaSensor’s device is a spectroscopy-based objective tool to help clinicians evaluate suspected lesions for some of the most common forms of skin cancer, including basal cell carcinoma ...

Was that mole always there? Photograph, track, and identify marks with these apps before you head to your dermatologist.

Early data suggests the device has a high detection rate for two other forms of skin cancer - basal cell and squamous cell carcinomas - and may identify precancerous lesions, says Dr. McLean, a ...

DermaSensor Inc. is a health technology company designing non-invasive tools to better equip primary care providers for skin cancer detection. The DermaSensor device is an affordable, handheld ...

The first medical device powered by artificial intelligence and designed to help doctors catch skin cancer has been approved by the U.S. Food and Drug Administration. Although not meant to be used ...

One in five Americans will develop skin cancer by the age of 70. That’s why regular skin checks are important for early detection along with consulting a doctor if you notice any unusual lesions or ...

Dermasensor Inc.’s elastic scattering spectroscopy device appears to have solved one of the more challenging issues in dermatology—early detection of skin cancers in individuals with darker skin tones ...

DermaSensor isn’t the only AI-based skin cancer detection device on the market. UK-based Skin Analytics’ DERM device captures dermoscopic images of skin lesions, which are then analysed by a ...

US-based DermaSensor has announced a newly published study showing that its AI-powered device can improve a primary care physician’s ability to assess moles of concern. In the prospective study ...